Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

11.85
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
5.40
Today|||52-Week Range
12.35
+80.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$277.6M

Company Description

Enzymotec Ltd. engages in supplying of specialty lipid-based products and solutions. The company develops, manufactures and markets bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies. It operates through following segments: Nutrition and VAYA Pharma. The Nutrition segment develops, and manufactures nutritional ingredients for infant formulas and dietary supplements. The VAYA Pharma segment develops, manufactures, and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel.

Contact Information

Enzymotec Ltd.
Sagi 2000 Industrial Park
Migdal HaEmeq Hazafon 23106
P:972747177177
Investor Relations:

Employees

Shareholders

Mutual fund holders4.53%
Other institutional23.00%
Individual stakeholders--

Top Executives

Erez IsraeliPresident & Chief Executive Officer
Efrat ManoffChief Operating Officer & Vice President
Dror IsraelChief Financial Officer & Vice President
Yael RichterVice President-Research & Development
Michelle CucciaVice President-Marketing